Loading Phase (Weeks 1 through 4) Tb-500: 2 to 2.5 mg twice weekly (Monday and Thursday) totaling 4 to 5 mg per week Bpc-157: 0.5 mg daily, either as single dose or split into 0.25 mg twice daily Maintenance Phase (Weeks 5 through 8 plus) Tb-500: 2 mg once weekly Bpc-157: 0.25 to 0.5 mg daily Critical Notes Use separate vials and syringes for each peptide Never mix Bpc-157 and Tb-500 in the same syringe Tb-500 can be injected anywhere subcutaneously Bpc-157 should ideally be injected near the injury site The critical implementation detail bears repeating: Bpc-157 and Tb-500 should never be combined into a single vial as peptides lose their effectiveness when mixed incorrectly
The product is aimed at diminishing undesired skin pigmentation, evening the skin's tone and improving its overall complexion
Additionally, a few commenters recommended that the risk adjustment should account for patient complexity and co-morbidities
Yu Y, Song J, Guo X, Wang S, Yang X, Chen L et al
Because it is a large molecule, choosing a high-quality, bioavailable form is necessary to ensure the body can actually use the building blocks provided
Significance of an unusually low Km for glutathione in glutathione transferases of the alpha, mu and pi classes
